Investor Relations


Nanōmix Corporation, Inc. (OTCQB: NNMX)

Nanōmix is the leader in the development of mobile, affordable point-of-care diagnostics, with a hand-held platform and assays that provide rapid, accurate, quantitative information for use in settings where time-to-diagnosis is critical to clinical decision making and improved patient care.

Click here for additional interviews and videos from Nanomix